E Premkumar Reddy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from E premkumar reddy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In E Premkumar Reddy Today - Breaking & Trending Today

Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 target price for the company […] ....

Ramesh Kumar , E Premkumar Reddy , Vanguard Group Inc , Onconova Therapeutics Company Profile , Millennium Management , Renaissance Technologies , Beacon Pointe Advisors , Onconova Therapeutics Inc , Onconova Therapeutics , Get Rating , Therapeutics Trading Down , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,

Onconova Therapeutics (NASDAQ:ONTX) Now Covered by StockNews.com

StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price target on the […] ....

E Premkumar Reddy , Ramesh Kumar , Onconova Therapeutics Inc , Millennium Management , Vanguard Group Inc , Beacon Pointe Advisors , Onconova Therapeutics Company Profile , Renaissance Technologies , Onconova Therapeutics , Get Rating , Pointe Advisors , Onconova Therapeutics Daily ,

Onconova Therapeutics (NASDAQ:ONTX) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a “neutral” rating to a “buy” rating and set a $11.00 price target on […] ....

E Premkumar Reddy , Ramesh Kumar , Onconova Therapeutics Inc , Beacon Pointe Advisors , Vanguard Group Inc , Renaissance Technologies , Millennium Management , Onconova Therapeutics , Get Rating , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily ,

Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price objective on the stock in a […] ....

Ramesh Kumar , E Premkumar Reddy , Millennium Management , Beacon Pointe Advisors , Onconova Therapeutics Inc , Renaissance Technologies , Onconova Therapeutics Company Profile , Vanguard Group Inc , Onconova Therapeutics , Get Rating , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,

Short Interest in Onconova Therapeutics, Inc. (NASDAQ:ONTX) Declines By 24.8%

Onconova Therapeutics, Inc. (NASDAQ:ONTX – Get Rating) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 291,400 shares, a drop of 24.8% from the April 30th total of 387,400 shares. Based on an average daily volume of 540,800 shares, the days-to-cover ratio is […] ....

E Premkumar Reddy , Ramesh Kumar , Renaissance Technologies , Millennium Management , Vanguard Group Inc , Beacon Pointe Advisors , Onconova Therapeutics Inc , Onconova Therapeutics , Get Rating , Pointe Advisors , Vanguard Group , Therapeutics Stock Down , Onconova Therapeutics Daily , Nasdaq Ontx ,